C H Nightingale
Overview
Explore the profile of C H Nightingale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
277
Citations
2074
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Owens C, Ambrose P, Quintiliani R, Nightingale C, Nicolau D
Clin Drug Investig
. 2008 Mar;
15(6):531-5.
PMID: 18370511
No abstract available.
2.
Nightingale C
Clin Drug Investig
. 2007 May;
25(2):135-52.
PMID: 17523763
Objective: This study compared the quality of 65 generic clarithromycin products manufactured in 18 countries with that of the innovator product. Design: To assess quality, the generic products were examined...
3.
Niclau D, Tessier P, Rubinstein I, Nightingale C
Pharmazie
. 2006 May;
61(4):343-7.
PMID: 16649552
In addition to bactericidal activity, macrolide antibacterials possess clinically relevant properties such as immunomodulatory activity. Whether such activity extends to novel antibacterials that are structurally related to macrolides, such as...
4.
Ong C, Dandekar P, Sutherland C, Nightingale C, Nicolau D
Chemotherapy
. 2005 Oct;
51(6):339-46.
PMID: 16224186
Background: Antimicrobial efficacy is dependent on the ability of the agent to reach the site of infection. To assess the bronchopulmonary drug disposition of a novel ketolide, telithromycin (TEL), the...
5.
Florea N, Capitano B, Nightingale C, Hull D, Leitz G, Nicolau D
Transplant Proc
. 2003 Dec;
35(8):2873-7.
PMID: 14697925
Background: Itraconazole is often given for fungal prophylaxis to renal transplant recipients, who require concomitant cyclosporine in the immediate posttransplant period. We determined the extent of the pharmacokinetic interaction between...
6.
Kim M, Banevicius M, Zhong M, Shi X, Hu M, Nightingale C, et al.
Int J Artif Organs
. 2002 Feb;
25(1):33-9.
PMID: 11853069
Background: Quinupristin-dalfopristin (Q/D) is often utilized in critically ill patients, some of whom require CVVH. This study was undertaken to determine the clearance of O/D and their main active metabolites...
7.
Xuan D, Turley C, Nightingale C, Nicolau D
J Chromatogr B Biomed Sci Appl
. 2002 Jan;
765(1):37-43.
PMID: 11817308
A sensitive, simple, and accurate method for determination of BMS-284756, a novel des-F(6)-quinolone antimicrobial agent in mouse serum was developed by HPLC with fluorescence detection. Sample preparations were carried out...
8.
Capitano B, Quintiliani R, Nightingale C, Nicolau D
Paediatr Drugs
. 2001 Nov;
3(10):703-18.
PMID: 11706922
Although the overall incidence of infective endocarditis in the paediatric population is considered to be low, over the last 20 years a rising trend in infective endocarditis has been observed...
9.
McNabb J, Ross J, Abriola K, Turley C, Nightingale C, Nicolau D
Clin Infect Dis
. 2001 Aug;
33(5):700-5.
PMID: 11486292
This study's hypothesis is that human immunodeficiency virus-infected patients in the inner city (predominantly injection drug users and ethnic minorities) do not take highly active antiretroviral therapy (HAART) as prescribed...
10.
Kim M, Xuan D, Quintiliani R, Nightingale C, Nicolau D
J Antimicrob Chemother
. 2001 Aug;
48(2):259-67.
PMID: 11481298
A multiple-dose, open-labelled, randomized, two period crossover human volunteer study was performed (i) to describe the pharmacokinetic profile and safety profile of piperacillin and tazobactam (P/T) administered 6.0/0.75 g and...